ClearPoint Neuro and Blackrock Microsystems announce joint development agreement

ClearPoint Neuro announced a multi-product joint development and option agreement with Blackrock Microsystems to develop products for neurosurgery markets, including microelectrode recording platforms and smart biopsy needles. Initial product launches are expected in 2023.

“We are thrilled to announce this partnership with Blackrock and enter several existing Neurosurgery markets, representing an estimated combined addressable market of over $100 million, with differentiated and innovative products.”rss.globenewswire.com

• 1 source
• rss.globenewswire.comClearPoint Neuro, Inc. Announces Multi-Product JointClearPoint Neuro, Inc.Feb 11, 2021

Summarized from public sources; check the original articles before acting on it.